聯(lián)合降尿酸治療對原發(fā)性高血壓患者血壓形態(tài)的影響
發(fā)布時間：2018-11-15 13:29
【摘要】：[目的]聯(lián)合降尿酸治療,對伴有高尿酸血癥的原發(fā)性非杓型高血壓患者血壓形態(tài)的影響。[方法]收集2013年4月至2014年4月于泉州市第一醫(yī)院住院及門診臨床診斷為高尿酸血癥的原發(fā)性非杓型高血壓(1級或2級)患者136例,其中男性72例,女性64例,平均年齡(61.38±6.79)歲。隨機分為降尿酸組(n=68)和對照組(n=68),兩組降壓均以非洛地平緩釋片(波依定)5mg/d治療;降尿酸組在降壓的基礎上加用苯溴馬隆(爾同舒)50mg/d,共治療24周。比較兩組患者治療前后血清尿酸水平、動態(tài)血壓參數(shù)以及治療后兩組患者血壓達標率、非杓型血壓糾正率的差異和血壓晝夜差值百分比的差異。[結果]1.血清尿酸水平:治療后,降尿酸組血清尿酸水平明顯降低,與治療前相比(治療前466.30±60.39,治療后344.7±39.86,P0.01),具有顯著統(tǒng)計學差異;而對照組的血清尿酸水平(治療前468.40±60.37,治療后467.89±60.17,P=0.96),差異無明顯統(tǒng)計學意義。2.動態(tài)血壓結果顯示:治療后,降尿酸組及對照組均能顯著降低全天血壓。兩組白天血壓均值及24h血壓均值的差異無統(tǒng)計學意義,但是降尿酸組對夜間平均血壓的療效優(yōu)于對照組(降尿酸組n SBP:122.24±11.72,對照組n SBP:126.99±8.11,P0.01;降尿酸組n DBP:73.66±5.02,對照組n DBP:77.97±3.73,P0.01)。3.治療后,兩組的24h SBP、24h DBP和d SBP、d DBP的達標率(降尿酸組36.76%患者的24h SBP和24h DBP達標,對照組為33.82%,P0.05;降尿酸組30.88%患者的d SBP和d DBP達標,對照組為29.41%,P0.05),差異無統(tǒng)計學意義。但是兩組的n SBP和n DBP達標率(降尿酸組60.29%患者的n SBP和n DBP達標,對照組為19.11%,P0.01),差異有顯著統(tǒng)計學意義。4.治療后,降尿酸組將非杓型血壓糾正為杓型血壓的比例明顯上升(降尿酸組為55.88%,而對照組為13.24%,P0.01),差異有顯著統(tǒng)計學意義。5.治療后,降尿酸組的SBP、DBP晝夜差值百分比較對照組有明顯的上升(降尿酸組SBP晝夜差值百分比為8.75±7.67,對照組為3.99±6.93,P0.01;降尿酸組DBP晝夜差值百分比為11.59±3.42,對照組為4.58±6.79,P0.01),差異有顯著統(tǒng)計學意義。[結論]對于高尿酸血癥的原發(fā)性非杓型高血壓(1級或2級)患者,在降壓治療的基礎上聯(lián)合降尿酸治療,能夠更好地降低夜間血壓,并提高夜間血壓達標率及杓型血壓的比例。
[Abstract]:Objective: to study the effect of combined hypouric acid therapy on blood pressure in patients with essential non-dipper hypertension with hyperuricemia. [methods] from April 2013 to April 2014, 136 patients with primary non-dipper hypertension (grade 1 or grade 2) who were clinically diagnosed as hyperuricemia in the first Hospital of Quanzhou, including 72 males and 64 females, were collected. The average age was (61.38 鹵6.79) years. Two groups were randomly divided into two groups: noruric acid group (nong68) and control group (nong68). Both groups were treated with felodipine sustained-release tablets (Boyding) 5mg/d, and those in hypouric acid group were treated with 50 mg / d benzbromarone (Ertongshu) on the basis of hypotension for 24 weeks. The serum uric acid level, ambulatory blood pressure parameters, blood pressure reaching standard rate, non-dipper blood pressure correction rate and diurnal percentage of blood pressure were compared between the two groups before and after treatment. [result] 1. Serum uric acid level: after treatment, the serum uric acid level in the decreasing uric acid group was significantly lower than that before treatment (466.30 鹵60.39, 344.7 鹵39.86, P0.01). But the serum uric acid level of the control group (468.40 鹵60.37 before treatment and 467.89 鹵60.17 P0. 96 after treatment) had no significant difference. 2. The results of ambulatory blood pressure showed that after treatment, the blood pressure of all day was significantly decreased in both the control group and the lower uric acid group. There was no significant difference in daytime and 24h blood pressure between the two groups, but the effect of decreasing uric acid group on nocturnal mean blood pressure was better than that of control group (n SBP:122.24 鹵11.72, n SBP:126.99 鹵8.11 P 0.01). N DBP:73.66 鹵5.02 in hypouric acid group and n DBP:77.97 鹵3.73 in control group (P0.01). After treatment, the 24 h SBP,24h DBP and d SBP,d DBP of the two groups reached the standard (36.76% of the patients in the uric acid group reached the standard of 24 h SBP and 24 h DBP, the control group was 33.82%, P 0.05). D SBP and d DBP reached the standard in 30.88% of the patients in the uric acid group, and 29.41% in the control group (P0.05), the difference was not statistically significant. But n SBP and n DBP reached the standard rate (n SBP and n DBP reached the standard in 60.29% of the patients in the uric acid group and 19.11% in the control group), the difference was statistically significant. 4. After treatment, the proportion of non-dipper blood pressure corrected to dipper blood pressure was significantly increased in hypouric acid group (55.88% in the hypouric acid group, while 13.24% P0.01 in the control group), the difference was statistically significant (P < 0.05). After treatment, the percentage of diurnal difference of SBP,DBP in decreasing uric acid group was significantly higher than that in control group (8.75 鹵7.67 in decreasing uric acid group and 3.99 鹵6.93 in control group, P 0.01). The percentage of diurnal difference of DBP was 11.59 鹵3.42 in hypouric acid group and 4.58 鹵6.79 in control group (P 0.01). [conclusion] in hyperuricemia patients with primary non-dipper hypertension (grade 1 or grade 2), combined hypotensive therapy and hypouric acid therapy can lower nocturnal blood pressure better. The ratio of night-time blood pressure and dipper blood pressure was increased.
【學位授予單位】：福建醫(yī)科大學
【學位級別】：碩士
【學位授予年份】：2015
【分類號】：R544.1
本文編號：2333439
[Abstract]:Objective: to study the effect of combined hypouric acid therapy on blood pressure in patients with essential non-dipper hypertension with hyperuricemia. [methods] from April 2013 to April 2014, 136 patients with primary non-dipper hypertension (grade 1 or grade 2) who were clinically diagnosed as hyperuricemia in the first Hospital of Quanzhou, including 72 males and 64 females, were collected. The average age was (61.38 鹵6.79) years. Two groups were randomly divided into two groups: noruric acid group (nong68) and control group (nong68). Both groups were treated with felodipine sustained-release tablets (Boyding) 5mg/d, and those in hypouric acid group were treated with 50 mg / d benzbromarone (Ertongshu) on the basis of hypotension for 24 weeks. The serum uric acid level, ambulatory blood pressure parameters, blood pressure reaching standard rate, non-dipper blood pressure correction rate and diurnal percentage of blood pressure were compared between the two groups before and after treatment. [result] 1. Serum uric acid level: after treatment, the serum uric acid level in the decreasing uric acid group was significantly lower than that before treatment (466.30 鹵60.39, 344.7 鹵39.86, P0.01). But the serum uric acid level of the control group (468.40 鹵60.37 before treatment and 467.89 鹵60.17 P0. 96 after treatment) had no significant difference. 2. The results of ambulatory blood pressure showed that after treatment, the blood pressure of all day was significantly decreased in both the control group and the lower uric acid group. There was no significant difference in daytime and 24h blood pressure between the two groups, but the effect of decreasing uric acid group on nocturnal mean blood pressure was better than that of control group (n SBP:122.24 鹵11.72, n SBP:126.99 鹵8.11 P 0.01). N DBP:73.66 鹵5.02 in hypouric acid group and n DBP:77.97 鹵3.73 in control group (P0.01). After treatment, the 24 h SBP,24h DBP and d SBP,d DBP of the two groups reached the standard (36.76% of the patients in the uric acid group reached the standard of 24 h SBP and 24 h DBP, the control group was 33.82%, P 0.05). D SBP and d DBP reached the standard in 30.88% of the patients in the uric acid group, and 29.41% in the control group (P0.05), the difference was not statistically significant. But n SBP and n DBP reached the standard rate (n SBP and n DBP reached the standard in 60.29% of the patients in the uric acid group and 19.11% in the control group), the difference was statistically significant. 4. After treatment, the proportion of non-dipper blood pressure corrected to dipper blood pressure was significantly increased in hypouric acid group (55.88% in the hypouric acid group, while 13.24% P0.01 in the control group), the difference was statistically significant (P < 0.05). After treatment, the percentage of diurnal difference of SBP,DBP in decreasing uric acid group was significantly higher than that in control group (8.75 鹵7.67 in decreasing uric acid group and 3.99 鹵6.93 in control group, P 0.01). The percentage of diurnal difference of DBP was 11.59 鹵3.42 in hypouric acid group and 4.58 鹵6.79 in control group (P 0.01). [conclusion] in hyperuricemia patients with primary non-dipper hypertension (grade 1 or grade 2), combined hypotensive therapy and hypouric acid therapy can lower nocturnal blood pressure better. The ratio of night-time blood pressure and dipper blood pressure was increased.
【學位授予單位】：福建醫(yī)科大學
【學位級別】：碩士
【學位授予年份】：2015
【分類號】：R544.1
【參考文獻】
相關期刊論文 前8條
1 毛紹芬 ,李玉東 ,馮文化;高血壓病患者血尿酸水平的變化及臨床意義[J];中國醫(yī)師雜志;2002年11期
2 趙義發(fā);徐中林;;降尿酸治療對伴發(fā)無癥狀高尿酸血癥的高血壓患者血壓的影響[J];重慶醫(yī)學;2014年32期
3 張立建;侯維寧;;非杓型高血壓與尿酸的關系[J];海南醫(yī)學;2008年07期
4 周永列;陳永健;胡鑫瑜;;健康體檢人群高尿酸血癥患者中血清超敏C反應蛋白與胰島素抵抗的變化[J];浙江檢驗醫(yī)學;2008年02期
5 胡大一;丁榮晶;;無癥狀高尿酸血癥合并心血管疾病診治建議中國專家共識[J];中國全科醫(yī)學;2010年11期
6 傅彬;;非洛地平緩釋片治療老年高血壓的療效研究[J];實用心腦肺血管病雜志;2011年03期
7 蔡志軍;;高血壓伴高尿酸血癥的合理用藥[J];臨床合理用藥雜志;2010年09期
8 翟淼淼;方寧遠;;老年高血壓患者動態(tài)血壓與血清尿酸的關系[J];上海交通大學學報(醫(yī)學版);2014年08期
相關碩士學位論文 前1條
1 吳晶瑩;尿酸與原發(fā)性高血壓患者非杓型血壓形態(tài)的關系[D];福建醫(yī)科大學;2013年
，本文編號：2333439
本文鏈接：http://sikaile.net/yixuelunwen/xxg/2333439.html
最近更新
教材專著
